Autopsy report · NCT02514109

Clinical, Electrophysiological and Biological Diagnostic Criteria of Sensory Neuronopathies

“Start of a new study concerning the same patients”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 years 3 months after it had already started.
• Ran for about 6 years 3 months before it stopped.
• 80 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Sponsor type

University, hospital or other

Conditions

Neuronopathy

Interventions

Neurological assessment and Blood sample

Participants

80

Sites

12

Countries

France

Trials that died the same way

• Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC
  “Another study enrolling the similar group of patient are ongoing” (71% match in meaning)
• Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery
  “The study was stopped due to difficulties in including patients” (68% match in meaning)
• Double-Lumen Tube Intubation in the Lateral Position Versus the Supine Position on First-Attempt Success Rate
  “Similar studies have been conducted” (67% match in meaning)
• An Assessment of Voriconazole Pharmacokinetics and Pharmacogenetics in Liver Transplant Recipients - Pilot Study
  “Enrolled requested number of patients and completed study. In analysis” (66% match in meaning)
• Developmental Correlates and Hormone Therapy Effects in Gender Dysphoria
  “the patients are now followed in another hospital. The study is discontinued” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.